Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 289 clinical trials
featured
Addressing Real-world Anticoagulant Management Issues in Stroke (ARAMIS) Registry

Addressing Real-world Anticoagulant Management Issues in Stroke (ARAMIS) Registry

  • 68 views
  • 08 Nov, 2020
  • 1 location
featured
Management of Acute Stroke Patients on Treatment with New Oral Anticoagulants: Addressing Real-world Anticoagulant Management Issues in Stroke (ARAMIS) Registry”

Management of Acute Stroke Patients on Treatment with New Oral Anticoagulants: Addressing Real-world Anticoagulant Management Issues in Stroke (ARAMIS) Registry”

  • 284 views
  • 25 Mar, 2021
  • 1 location
featured
EINSTEIN CHOICE

EINSTEIN CHOICE

  • 352 views
  • 08 Nov, 2020
  • 1 location
featured
Need a Cardiac Stent?

Need a Cardiac Stent?

  • 324 views
  • 08 Nov, 2020
  • 1 location
featured
A multicenter clinical study of the Sonablate® 500 (Sonablate) for the TreAtment of locally Recurrent prostate cancer with HIFU(STAR Trial)

A multicenter clinical study of the Sonablate® 500 (Sonablate) for the TreAtment of locally Recurrent prostate cancer with HIFU(STAR Trial)

  • 196 views
  • 25 Mar, 2021
  • 1 location
featured
BRIDGE: Bridging Anticoagulation in Patients who Require Temporary Interruption of Warfarin Therapy for an Elective Invasive Procedure or Surgery

BRIDGE: Bridging Anticoagulation in Patients who Require Temporary Interruption of Warfarin Therapy for an Elective Invasive Procedure or Surgery

  • 30 views
  • 25 Mar, 2021
  • 1 location
  • 19 views
  • 25 Jan, 2021
  • 134 locations
Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion

direct oral anticoagulant (DOAC) with a safety profile superior to that of vitamin K antagonists. Given the safety profile, ease of use, and feasibility of DOAC therapy, our study will endeavor to

  • 11 views
  • 26 Jan, 2021
  • 1 location
Clinical Study of Argatroban in the Treatment of Acute Progressive Ischemic Stroke

guidelines in the United States do not recommend it as a routine anticoagulant therapy. Therefore, reducing the risk of bleeding is the key to the anticoagulation therapy of PIS. Argatroban is a new

  • 0 views
  • 25 Jan, 2021
  • 6 locations
Risk-Based Screening for the Evaluation of Atrial Fibrillation Trial

To determine whether a risk-based screening programme for occult paroxysmal atrial fibrillation, involving extended cardiac monitoring in adults with CHA2DS2-VASc score of 3 or greater, increases the detection of new atrial fibrillation/flutter. To determine whether a risk-based screening programme for occult paroxysmal atrial fibrillation, involving extended cardiac monitoring in adults …

  • 47 views
  • 25 Jan, 2021
  • 1 location